Digital Health: Significant FDA Policy Developments In 2022 - Healthcare

In 2022, FDA retreated from a flexible approach to its regulation of digital health in two key areas: (1) its PreCertification Program for software as a medical device (SaMD) and (2) its guidance...

Related Keywords

Scott Gottlieb ,Software Precertification Program ,Precertification Program ,International Medical Device Regulators Forum ,Precert Program ,Health It Report Proposed Strategy ,Software Precertification Pre ,Framework For Conducting The Pilot Program ,International Medical Device ,Drug Administration Staff ,Clinical Decision Support Software ,Enforcement Discretion ,Drug Administration ,Cert Program ,Clinical Decision Support Software Guidance ,Patient Decision Support Software ,Unworkable Program ,Clinical Decision Support ,Software Precertification ,Pre Cert Program ,Excellence Appraisal ,Review Determination ,Streamlined Review ,Working Model ,Excellence Approval ,Federal Food ,Cosmetic Act ,Test Plan ,Key Performance Indicators ,Final Guidance ,Clinical Decisions Support ,Century Cures Act ,Limited Enforcement ,Pilot Program ,Ongoing Activities ,New Steps ,Empower Consumers ,Advance Digital Healthcare ,Cert Report ,Proposed Strategy ,Risk Based Framework ,Decision Support Software Guidance ,Draft Guidance ,Decision Support Software ,Possible Framework ,Risk Categorization ,International Medical Device Regulators ,Mondaq ,Digital Health Significant Fda Policy Developments In 2022 ,Food ,Drugs ,Healthcare ,Life Sciences ,Food And Drugs Law ,Iotechnology Amp Nanotechnology , ,